These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Kakio A; Nishimoto S; Yanagisawa K; Kozutsumi Y; Matsuzaki K Biochemistry; 2002 Jun; 41(23):7385-90. PubMed ID: 12044171 [TBL] [Abstract][Full Text] [Related]
23. Activation of macrophages by Alzheimer beta amyloid peptide. Klegeris A; Walker DG; McGeer PL Biochem Biophys Res Commun; 1994 Mar; 199(2):984-91. PubMed ID: 7510964 [TBL] [Abstract][Full Text] [Related]
24. Direct interaction of soluble human recombinant tau protein with Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II. Rank KB; Pauley AM; Bhattacharya K; Wang Z; Evans DB; Fleck TJ; Johnston JA; Sharma SK FEBS Lett; 2002 Mar; 514(2-3):263-8. PubMed ID: 11943163 [TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and evaluation of Trolox-conjugated amyloid-β C-terminal peptides for therapeutic intervention in an in vitro model of Alzheimer's disease. Arai T; Ohno A; Kazunori M; Kakizawa T; Kuwata H; Ozawa T; Shibanuma M; Hara S; Ishida S; Kurihara M; Miyata N; Nakagawa H; Fukuhara K Bioorg Med Chem; 2016 Sep; 24(18):4138-4143. PubMed ID: 27407032 [TBL] [Abstract][Full Text] [Related]
26. Critical role of interfaces and agitation on the nucleation of Abeta amyloid fibrils at low concentrations of Abeta monomers. Morinaga A; Hasegawa K; Nomura R; Ookoshi T; Ozawa D; Goto Y; Yamada M; Naiki H Biochim Biophys Acta; 2010 Apr; 1804(4):986-95. PubMed ID: 20100601 [TBL] [Abstract][Full Text] [Related]
27. Chemical modifications of amyloid-β(1-42) have a significant impact on the repertoire of brain amyloid-β(1-42) binding proteins. Medvedev AE; Buneeva OA; Kopylov AT; Mitkevich VA; Kozin SA; Zgoda VG; Makarov AA Biochimie; 2016; 128-129():55-8. PubMed ID: 27400251 [TBL] [Abstract][Full Text] [Related]
28. TREM1 facilitates microglial phagocytosis of amyloid beta. Jiang T; Zhang YD; Gao Q; Zhou JS; Zhu XC; Lu H; Shi JQ; Tan L; Chen Q; Yu JT Acta Neuropathol; 2016 Nov; 132(5):667-683. PubMed ID: 27670763 [TBL] [Abstract][Full Text] [Related]
29. Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages. Yazawa H; Yu ZX; Takeda ; Le Y; Gong W; Ferrans VJ; Oppenheim JJ; Li CC; Wang JM FASEB J; 2001 Nov; 15(13):2454-62. PubMed ID: 11689470 [TBL] [Abstract][Full Text] [Related]
30. Amyloid beta-peptide induces cholinergic dysfunction and cognitive deficits: a minireview. Tran MH; Yamada K; Nabeshima T Peptides; 2002 Jul; 23(7):1271-83. PubMed ID: 12128084 [TBL] [Abstract][Full Text] [Related]
31. Engineering of a peptide probe for β-amyloid aggregates. Aoraha E; Candreva J; Kim JR Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444 [TBL] [Abstract][Full Text] [Related]
32. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide. Cottingham MG; Hollinshead MS; Vaux DJ Biochemistry; 2002 Nov; 41(46):13539-47. PubMed ID: 12427014 [TBL] [Abstract][Full Text] [Related]
34. Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation. Oyama R; Yamamoto H; Titani K Biochim Biophys Acta; 2000 Jun; 1479(1-2):91-102. PubMed ID: 11004532 [TBL] [Abstract][Full Text] [Related]
35. Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo. Suo Z; Humphrey J; Kundtz A; Sethi F; Placzek A; Crawford F; Mullan M Neurosci Lett; 1998 Nov; 257(2):77-80. PubMed ID: 9865931 [TBL] [Abstract][Full Text] [Related]
36. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Coraci IS; Husemann J; Berman JW; Hulette C; Dufour JH; Campanella GK; Luster AD; Silverstein SC; El-Khoury JB Am J Pathol; 2002 Jan; 160(1):101-12. PubMed ID: 11786404 [TBL] [Abstract][Full Text] [Related]
37. Rapid α-oligomer formation mediated by the Aβ C terminus initiates an amyloid assembly pathway. Misra P; Kodali R; Chemuru S; Kar K; Wetzel R Nat Commun; 2016 Aug; 7():12419. PubMed ID: 27546208 [TBL] [Abstract][Full Text] [Related]
38. Decreased expression of cathepsin D in monocytes is related to the defective degradation of amyloid-β in Alzheimer's disease. Tian L; Zhang K; Tian ZY; Wang T; Shang DS; Li B; Liu DX; Fang WG; Wang ZY; Chen YH J Alzheimers Dis; 2014; 42(2):511-20. PubMed ID: 24898658 [TBL] [Abstract][Full Text] [Related]
39. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease. Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549 [TBL] [Abstract][Full Text] [Related]
40. ERK pathway activation is required for amyloid-β(1-40)(-)induced neurotoxicity of THP-1 human monocytes towards SK-N-SH neuroblastoma. Yin LL; Li W; Chu YQ; Li L Brain Res; 2011 Mar; 1378():9-17. PubMed ID: 21241676 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]